First fixed drug eruption due to teicoplanin with a peri-oral distribution

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 9, 2009, Pages 1107-

  Hadj Rabia, S ^a   Duong, T ^a,d   Hamel, D ^a   Benlahrech, S ^a   Le Quan Sang, K H ^b   Sauve Martin H ^c   De Prost, Y ^e   Roujeau, J C ^d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Centre Therapeutique Pediatrique   (France)

^d HENRI MONDOR HOSPITAL   (France)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETAMETHASONE DIPROPIONATE; DEXCHLORPHENIRAMINE; RIFAMYCIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CASE REPORT; CHEILITIS; CHILD; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FIXED DRUG ERUPTION; HUMAN; LETTER; LIP EDEMA; PRIORITY JOURNAL; SCHOOL CHILD; SKIN DEFECT; STAPHYLOCOCCAL BACTEREMIA;

ANTI-BACTERIAL AGENTS; CHILD; DRUG ERUPTIONS; FEMALE; HUMANS; MOUTH; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICOPLANIN;

EID: 68749118718     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03108.x     Document Type: Letter

References (4)

1. Savin JA. Current causes of fixed drug eruption in the UK. Br J Dermatol 2001 145 : 667 668.
2. Prey S, Sparsa A, Boumediene A et al. Cutaneous drug reactions induced by glycopeptides. Med Mal Infect 2007 37 : 270 274.
3. Gilmore ES, Friedman JS, Morrell DS. Extensive fixed drug eruption secondary to vancomycin. Pediatr Dermatol 2004 21 : 600 602.
4. Unal S, Ikizoglu G, Demirkan F, Kaya TI. Teicoplanin-induced skin eruption. Int J Dermatol 2002 41 : 948 949.